CompletedNot Applicable

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

United States14,390 participantsStarted 2022-03-14

Plain-language summary

A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women (≥ 18 years of age) who have provided informed consent for the study. Exclusion Criteria: * Participants with prior history of FNAIT

What they're measuring

Number of participants with higher FNAIT risk characterized by race and ethnicity

Timeframe: At inclusion

Trial details

NCT IDNCT05345561

SponsorRallybio

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Fetal and Neonatal Alloimmune Thrombocytopenia trials